• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CK1α 过表达与结直肠癌患者的不良预后相关。

CK1α overexpression correlates with poor survival in colorectal cancer.

机构信息

Department of General and Visceral Surgery, Ulm University Hospital, Albert-Einstein-Allee 23, 89081, Ulm, Germany.

Ulm University, Institute of General Physiology, Albert-Einstein-Allee 11, 89081, Ulm, Germany.

出版信息

BMC Cancer. 2018 Feb 6;18(1):140. doi: 10.1186/s12885-018-4019-0.

DOI:10.1186/s12885-018-4019-0
PMID:29409464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5801892/
Abstract

BACKGROUND

Colorectal cancer (CRC) is the fourth leading cause of cancer related deaths worldwide and prognosis in advanced tumor stage still remains poor. Since CK1 isoforms have been reported to be deregulated in several tumor entities CK1 has emerged as a novel drug target in cancer therapy. In this study we set out to investigate whether CK1α might have the potential to serve as prognostic marker.

METHODS

CK1α RNA and protein expression levels in healthy and tumor tissue of CRC patients were analyzed using quantitative real-time PCR and Western Blot analysis, respectively. Prognostic relevance was investigated by correlating obtained CK1α expression levels with patients' survival rate generating Kaplan-Meier survival plots.

RESULTS

It could be shown that CK1α is overexpressed in colorectal tumor tissue compared to normal tissue and CK1α overexpression in tumor tissue correlates with poor survival in CRC patients. Results become more significant when only considering patients with high-grade tumors, as well as patients assigned to UICC II and UICC III stage. Furthermore, Cox regression analysis revealed that CK1α is an independent prognostic factor. In addition, tumors expressing decreased levels of the kinase reveal positive effects on overall survival when localized in the right colon compared to those in the left side.

CONCLUSION

In summary, this study provides evidence for the first time that CK1α RNA levels might serve as prognostic marker for CRC.

摘要

背景

结直肠癌(CRC)是全球癌症相关死亡的第四大主要原因,晚期肿瘤的预后仍然较差。由于 CK1 同工型已在几种肿瘤实体中被报道失调,因此 CK1 已成为癌症治疗的新药物靶点。在这项研究中,我们着手研究 CK1α 是否有可能作为预后标志物。

方法

使用定量实时 PCR 和 Western Blot 分析分别分析了 CRC 患者的健康组织和肿瘤组织中的 CK1α RNA 和蛋白表达水平。通过生成 Kaplan-Meier 生存图,将获得的 CK1α 表达水平与患者的生存率相关联,来研究预后相关性。

结果

结果表明,与正常组织相比,结直肠肿瘤组织中 CK1α 过表达,并且肿瘤组织中 CK1α 的过表达与 CRC 患者的不良预后相关。仅考虑高级别肿瘤患者以及 UICC II 和 UICC III 期患者时,结果更为显著。此外,Cox 回归分析表明 CK1α 是独立的预后因素。此外,与左侧相比,当位于右侧结肠时,表达降低的激酶的肿瘤对总生存期有积极影响。

结论

综上所述,本研究首次提供了证据,表明 CK1α RNA 水平可能作为 CRC 的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/1e009b102171/12885_2018_4019_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/d5305065f52d/12885_2018_4019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/86128d4d7d04/12885_2018_4019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/1e009b102171/12885_2018_4019_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/d5305065f52d/12885_2018_4019_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/86128d4d7d04/12885_2018_4019_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a685/5801892/1e009b102171/12885_2018_4019_Fig3_HTML.jpg

相似文献

1
CK1α overexpression correlates with poor survival in colorectal cancer.CK1α 过表达与结直肠癌患者的不良预后相关。
BMC Cancer. 2018 Feb 6;18(1):140. doi: 10.1186/s12885-018-4019-0.
2
Decreased CK1δ expression predicts prolonged survival in colorectal cancer patients.细胞周期蛋白依赖性激酶1δ(CK1δ)表达降低预示着结直肠癌患者生存期延长。
Tumour Biol. 2016 Jul;37(7):8731-9. doi: 10.1007/s13277-015-4745-8. Epub 2016 Jan 7.
3
Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.细胞周期蛋白依赖性激酶1δ和ɛ的表达及活性水平改变对结直肠癌患者肿瘤生长和生存的影响。
Int J Cancer. 2015 Jun 15;136(12):2799-810. doi: 10.1002/ijc.29346. Epub 2014 Dec 1.
4
Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.溶酶体酸性磷酸酶2是一个不良预后因素,但与接受化疗的II期结直肠癌患者更好的生存率相关。
Oncotarget. 2017 Feb 14;8(7):12120-12132. doi: 10.18632/oncotarget.14552.
5
Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients.Spondin-2的上调预示着结直肠癌患者的不良生存。
Oncotarget. 2015 Jun 20;6(17):15095-110. doi: 10.18632/oncotarget.3822.
6
MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.微小RNA 211表达上调与结直肠癌预后不良相关:一项病例对照研究
Tumour Biol. 2015 Dec;36(12):9703-9. doi: 10.1007/s13277-015-3708-4. Epub 2015 Jul 8.
7
Increased expression of Rab5A predicts metastasis and poor prognosis in colorectal cancer patients.Rab5A表达增加预示着结直肠癌患者发生转移且预后不良。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6974-80. eCollection 2015.
8
Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer.长链非编码RNA:早期结直肠癌患者肝转移的新型预后生物标志物。
Oncotarget. 2016 Aug 2;7(31):50428-50436. doi: 10.18632/oncotarget.10416.
9
Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma.碳酸酐酶VII在结直肠癌中的预后价值
BMC Cancer. 2015 Apr 1;15:209. doi: 10.1186/s12885-015-1216-y.
10
High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.癌细胞中PFTK1的高表达预示着结直肠癌的预后不良。
Mol Med Rep. 2017 Jul;16(1):224-230. doi: 10.3892/mmr.2017.6560. Epub 2017 May 10.

引用本文的文献

1
The Significance of the Wnt/β-Catenin Pathway and Related Proteins in Gastrointestinal Malignancies.Wnt/β-连环蛋白信号通路及相关蛋白在胃肠道恶性肿瘤中的意义
Int J Mol Sci. 2025 Aug 22;26(17):8130. doi: 10.3390/ijms26178130.
2
Epigenetic regulatory protein chromobox family regulates multiple signalling pathways and mechanisms in cancer.表观遗传调节蛋白染色质盒家族在癌症中调节多种信号通路和机制。
Clin Epigenetics. 2025 Mar 13;17(1):48. doi: 10.1186/s13148-025-01852-w.
3
Casein Kinase 1α-A Target for Prostate Cancer Therapy?酪蛋白激酶1α——前列腺癌治疗的一个靶点?

本文引用的文献

1
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.在小鼠结肠癌模型中,树突状细胞与来那度胺联合治疗是增强抗肿瘤免疫力的有效方法。
Oncotarget. 2017 Apr 18;8(16):27252-27262. doi: 10.18632/oncotarget.15917.
2
Colonic inflammation accompanies an increase of β-catenin signaling and Lachnospiraceae/Streptococcaceae bacteria in the hind gut of high-fat diet-fed mice.在高脂饮食喂养的小鼠后肠中,结肠炎症伴随着β-连环蛋白信号传导以及毛螺菌科/链球菌科细菌数量的增加。
J Nutr Biochem. 2016 Sep;35:30-36. doi: 10.1016/j.jnutbio.2016.05.015. Epub 2016 Jun 19.
3
Cancers (Basel). 2024 Jul 2;16(13):2436. doi: 10.3390/cancers16132436.
4
Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines.选择性细胞周期蛋白依赖性激酶1α(CK1α)降解剂对多种人类癌细胞系具有抗增殖活性。
Nat Commun. 2024 Jan 16;15(1):482. doi: 10.1038/s41467-024-44698-1.
5
Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer.Wnt/β-连环蛋白信号通路在结直肠癌发生发展中的作用
Cancer Manag Res. 2023 May 23;15:435-448. doi: 10.2147/CMAR.S411168. eCollection 2023.
6
DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.DKK3 的表达与免疫抑制和胶质母细胞瘤的预后不良相关,与低级别胶质瘤相反。
BMC Neurol. 2023 May 6;23(1):183. doi: 10.1186/s12883-023-03236-0.
7
A kinome-wide CRISPR screen identifies CK1α as a target to overcome enzalutamide resistance of prostate cancer.全激酶组 CRISPR 筛选鉴定 CK1α 为克服前列腺癌恩杂鲁胺耐药的靶点。
Cell Rep Med. 2023 Apr 18;4(4):101015. doi: 10.1016/j.xcrm.2023.101015.
8
Casein kinase 1α mediates eryptosis: a review.酪蛋白激酶1α介导红细胞凋亡:综述
Apoptosis. 2023 Feb;28(1-2):1-19. doi: 10.1007/s10495-022-01776-3. Epub 2022 Oct 29.
9
CK1α-targeting inhibits primary and metastatic colorectal cancer , , in cell-line-derived and patient-derived tumor xenograft mice models.在细胞系来源和患者来源的肿瘤异种移植小鼠模型中,靶向细胞角蛋白1α(CK1α)可抑制原发性和转移性结直肠癌。
Transl Cancer Res. 2020 Mar;9(3):1903-1913. doi: 10.21037/tcr.2020.02.13.
10
Casein Kinase-1-Alpha Inhibitor (D4476) Sensitizes Microsatellite Instable Colorectal Cancer Cells to 5-Fluorouracil via Authophagy Flux Inhibition.酪蛋白激酶-1-α抑制剂(D4476)通过抑制自噬通量使微卫星不稳定结直肠癌细胞对 5-氟尿嘧啶敏感。
Arch Immunol Ther Exp (Warsz). 2021 Sep 18;69(1):26. doi: 10.1007/s00005-021-00629-2.
Visfatin is involved in promotion of colorectal carcinoma malignancy through an inducing EMT mechanism.
内脂素通过诱导上皮-间质转化机制参与促进结直肠癌的恶性进展。
Oncotarget. 2016 May 31;7(22):32306-17. doi: 10.18632/oncotarget.8615.
4
Colorectal Cancer: Epidemiology, Disease Mechanisms and Interventions to Reduce Onset and Mortality.结直肠癌:流行病学、疾病机制以及降低发病率和死亡率的干预措施
Clin Colorectal Cancer. 2016 Sep;15(3):195-203. doi: 10.1016/j.clcc.2016.02.008. Epub 2016 Feb 13.
5
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine.高微卫星不稳定性(MSI-H)结直肠癌:个性化医疗时代预测生物标志物的简要综述
Fam Cancer. 2016 Jul;15(3):405-12. doi: 10.1007/s10689-016-9884-6.
6
Pharmacologic resistance in colorectal cancer: a review.结直肠癌中的药理学耐药性:综述
Ther Adv Med Oncol. 2016 Jan;8(1):57-84. doi: 10.1177/1758834015614530.
7
Decreased CK1δ expression predicts prolonged survival in colorectal cancer patients.细胞周期蛋白依赖性激酶1δ(CK1δ)表达降低预示着结直肠癌患者生存期延长。
Tumour Biol. 2016 Jul;37(7):8731-9. doi: 10.1007/s13277-015-4745-8. Epub 2016 Jan 7.
8
Gut Microbiota and Colorectal Cancer.肠道微生物群与结直肠癌
Gastrointest Tumors. 2015 May;2(1):26-32. doi: 10.1159/000380892. Epub 2015 Apr 22.
9
Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer.抑制酪蛋白激酶 1α 可预防 EGFR 突变型非小细胞肺癌对厄洛替尼的获得性耐药。
Cancer Res. 2015 Nov 15;75(22):4937-48. doi: 10.1158/0008-5472.CAN-15-1113. Epub 2015 Oct 21.
10
Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS.来那度胺诱导del(5q)骨髓增生异常综合征中CK1α的泛素化和降解。
Nature. 2015 Jul 9;523(7559):183-188. doi: 10.1038/nature14610. Epub 2015 Jul 1.